Hermann Martina, König Sebastian, Laxar Daniel, Krall Christoph, Kraft Felix, Krenn Katharina, Baumgartner Clemens, Tretter Verena, Maleczek Mathias, Hermann Alexander, Fraunschiel Melanie, Ullrich Roman
Department of Anaesthesia, General Intensive Care and Pain Medicine, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria.
Ludwig Boltzmann Institute for Digital Health and Patient Safety, Währingerstraße 104/10, 1180 Vienna, Austria.
J Clin Med. 2024 Aug 27;13(17):5094. doi: 10.3390/jcm13175094.
Although extracorporeal membrane ventilation offers the possibility for low-frequency ventilation, protocols commonly used in patients with acute respiratory distress syndrome (ARDS) and treated with extracorporeal membrane oxygenation (ECMO) vary largely. Whether strict adherence to low-frequency ventilation offers benefit on important outcome measures is poorly understood. : This pilot clinical study investigated the efficacy of low-frequency ventilation on ventilator-free days (VFDs) in patients suffering from ARDS who were treated with ECMO therapy. : In this single-center randomized controlled trial, 44 (70% male) successive ARDS patients treated with ECMO (aged 56 ± 12 years, SAPS III 64 (SD ± 14)) were randomly assigned 1:1 to the control group (conventional ventilation) or the treatment group (low-frequency ventilation during first 72 h on ECMO: respiratory rate 4-5/min; PEEP 14-16 cm HO; plateau pressure 23-25 cm HO, tidal volume: <4 mL/kg). The primary endpoint was VFDs at day 28 after starting ECMO treatment. The major secondary endpoint was ICU mortality, 28-day mortality and 90-day mortality. Twenty-three (52%) patients were successfully weaned from ECMO and were discharged from the intensive care unit (ICU). Twelve patients in the treatment group and five patients in the control group showed more than one VFD at day 28 of ECMO treatment. VFDs were 3.0 (SD ± 5.5) days in the control group and 5.4 (SD ± 6) days in the treatment group ( = 0.117). Until day 28 of ECMO initiation, patients in the treatment group could be successfully weaned off of the ventilator more often (OR of 0.164 of 0 VFDs at day 28 after ECMO start; 95% CI 0.036-0.758; = 0.021). ICU mortality did not differ significantly (36% in treatment group and 59% in control group; = 0.227). : Low-frequency ventilation is comparable to conventional protective ventilation in patients with ARDS who have been treated with ECMO. However, low-frequency ventilation may support weaning from invasive mechanical ventilation in patients suffering from ARDS and treated with ECMO therapy.
尽管体外膜肺氧合提供了低频通气的可能性,但急性呼吸窘迫综合征(ARDS)患者接受体外膜肺氧合(ECMO)治疗时常用的方案差异很大。严格坚持低频通气是否能在重要的预后指标上带来益处,目前还知之甚少。本前瞻性临床研究调查了低频通气对接受ECMO治疗的ARDS患者无呼吸机天数(VFD)的疗效。在这项单中心随机对照试验中,44例(70%为男性)连续接受ECMO治疗的ARDS患者(年龄56±12岁,简化急性生理学评分系统III为64(标准差±14))被1:1随机分配至对照组(传统通气)或治疗组(ECMO治疗的前72小时进行低频通气:呼吸频率4-5次/分钟;呼气末正压14-16厘米水柱;平台压23-25厘米水柱,潮气量:<4毫升/千克)。主要终点是开始ECMO治疗后第28天的无呼吸机天数。主要次要终点是重症监护病房死亡率、28天死亡率和90天死亡率。23例(52%)患者成功脱离ECMO并从重症监护病房(ICU)出院。在ECMO治疗第28天,治疗组有12例患者,对照组有5例患者显示有不止1个无呼吸机天数。对照组的无呼吸机天数为3.0(标准差±5.5)天,治疗组为5.4(标准差±6)天(P=0.117)。直到开始ECMO治疗的第28天,治疗组患者更常能成功脱机(ECMO开始后第28天无无呼吸机天数的比值比为0.164;95%置信区间0.036-0.758;P=0.021)。重症监护病房死亡率无显著差异(治疗组为36%,对照组为59%;P=0.227)。对于接受ECMO治疗的ARDS患者,低频通气与传统保护性通气相当。然而低频通气可能有助于接受ECMO治疗的ARDS患者脱离有创机械通气。